Pharmaceutical formulation containing gelling agent
Granted 14 Apr 2015 · 4 office actions
Assignee: Purdue Pharma
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Benjamin Oshlack, Curtis Wright, Christopher Breder · Examiner: Robert A Wax · AU 1615 · TC 1600
Life of the patent
13 dated eventsAbstract
Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
Claims
9 · 3 independent · depth 2Classifications
13 codes- A61K31/192
- A61K9/20
- A61K47/10
- A61K47/36
- A61K31/167
- A61K45/06
- A61K31/439
- A61K47/38
- A61K9/00
- A61K31/485
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this patent are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockTerm & fees
See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.
Log in to unlockPriority chain
2 priority documents›Priority documents — 2
| Type | Document | Date |
|---|---|---|
| provisional | US 60310534 | 6 Aug 2001 |
| related publication | US 20130261143 A1 | 3 Oct 2013 |
Validity challenges
See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.
Log in to unlockCitations
See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.
Log in to unlock